Target intelligence / Profile preview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD)

Target
PIK3CD
Molecular classification
Enzyme, Kinase, Transferase, Lipid kinase
01

Overview

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD, also known as p110δ) is a class IA phosphoinositide 3-kinase (PI3K) catalytic subunit predominantly expressed in leukocytes. It plays a critical role in the development, differentiation, and activation of B and T lymphocytes by generating the second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP3), which activates downstream AKT/mTOR signaling pathways. Dysregulation of PIK3CD is heavily implicated in human diseases; somatic gain-of-function mutations or overexpression are associated with hematological malignancies such as chronic lymphocytic leukemia (CLL) and various lymphomas, while germline gain-of-function mutations cause Activated PI3K-delta Syndrome (APDS), a primary immunodeficiency characterized by lymphoproliferation and recurrent infections.\n\nConsequently, PIK3CD has emerged as a major therapeutic target. Small-molecule inhibitors, such as idelalisib and leniolisib, are designed to selectively block its kinase activity to treat lymphomas and APDS, respectively. However, therapeutic targeting of PIK3CD is associated with significant safety challenges, including severe immune-mediated toxicities like colitis, hepatotoxicity, and pneumonitis, which are largely driven by the depletion of regulatory T cells.

Other names
Phosphatidylinositol 3-kinase p110δPhosphatidylinositol 3-kinase catalytic subunit deltaPhosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit deltaPI3-kinase subunit deltaPI3K-deltap110deltaPtdIns-3-kinase subunit p110-deltaPhosphoinositide-3-kinase catalytic delta polypeptide
02

Mechanism of action

Phosphatidylinositol 3-kinase delta inhibitor

03

Biological functions

Signal transductionCell growthCell proliferationCell differentiationImmune responseB-cell activationT-cell activationPhosphorylation
04

Disease associations

CancerActivated PI3K-delta syndromePrimary immunodeficiencyLymphomaLeukemiaAutoimmunityInflammation
05

Safety considerations

HepatotoxicitySevere diarrheaColitisPneumonitisInfectionsNeutropeniaIntestinal perforationDecreased regulatory T-cell activity
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

PIK3CD gain-of-function mutationsS6K phosphorylationAKT phosphorylationPIK3CD expression levelsB-cell counts

Beyond the preview

Go deeper on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PIK3CD).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call